Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Additionally we are shipping Lectin, Galactoside-Binding, Soluble, 4 Kits (50) and Lectin, Galactoside-Binding, Soluble, 4 Proteins (19) and many more products for this protein.
Showing 10 out of 81 products:
Yeast Monoclonal LGALS4 Primary Antibody for IP, WB - ABIN264526
Stone, Sadowski: GAL4 is regulated by a glucose-responsive functional domain. in The EMBO journal 1993
Show all 3 references for ABIN264526
Yeast Monoclonal LGALS4 Primary Antibody for IP, WB - ABIN264527
Carey, Kakidani, Leatherwood, Mostashari, Ptashne: An amino-terminal fragment of GAL4 binds DNA as a dimer. in Journal of molecular biology 1990
Show all 3 references for ABIN264527
Human Polyclonal LGALS4 Primary Antibody for EIA, FACS - ABIN952437
Zimbardi, Pinheiro, Dias-Baruffi, Nonato: Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the N-terminal carbohydrate-recognition domain of human galectin-4. in Acta crystallographica. Section F, Structural biology and crystallization communications 2010
Show all 2 references for ABIN952437
Xgalectin-VIa possesses different features from other cement gland genes and is a novel and useful marker of the cement gland in developing embryos.
patterns of galectin-4 and galectin-6 expression in the normal and the dextran sodium sulfate (DSS (show PMP22 Antibodies))-damaged digestive
structure of galectin-4 and binding properties of the N-terminal domain carbohydrate-recognition domain (CRD)1 were further investigated and the crystal structure of CRD1 in complex with lactose was determined at 2.1 A resolution
The galectin-4-mediated stimulation of CD4 (show CD4 Antibodies)(+) T cells is shown to exacerbate chronic colitis and delay the recovery from acute intestinal injury
While the CRD2 domain of galectin-4 has a high specificity and affinity for A type-2 alpha-GalNAc structures, the CRD1 domain has a broader specificity in correlation to the total binding profile.
X-ray analysis of the N-terminal domain of colon cancer marker Gal-4 is revealed in complex with lactose (the basic building block of known galectin-4 carbohydrate ligands).
galectin-4 plays a unique role in the intestine and assign a novel role of this protein in controlling intestinal inflammation by a selective induction of T cell apoptosis and cell cycle restriction
The data suggests that arm-Gal4 has detrimental effects on Drosophila development and lifespan that are directly dependent upon parental inheritance
The co-expression of galectin-4 and CNT3 (show SLC28A3 Antibodies) proteins is not impaired in inflamed colon from patients with Crohn's disease, thereby anticipating the integrity of this system for drug targeting.
Structural characterization of human galectin 4 C-terminal domain in terms its ligands binding specificity has been reported.
some galectins, particularly galectin-3 and -4, showed the ability to drive clathrin-independent mechanisms of endocytosis.
The results show galectin-4 expression closely associates with hepatocellular carcinoma (HCC (show FAM126A Antibodies)) progression and might have potential use as a prognostic biomarker for HCC (show FAM126A Antibodies) patients.
Results suggest that galectin-3 (show LGALS3 Antibodies), -4, -7 and -9 could be involved in the biology of inverted papillomas.
Galectin-4 plays an important role in metastatic process of lung adenocarcinoma.
The increased circulation of galectins -2, -4 and -8 in cancer patients contributes substantially to the increased circulation of G-CSF (show CSF3 Antibodies), IL-6 (show IL6 Antibodies) and MCP-1 (show CCL2 Antibodies) by interaction with the blood vascular endothelium
Data indicate that galectin-4 elicits tumor promotion in vitro and in vivo through activation of IL-6 (show IL6 Antibodies)/NF-kappaB (show NFKB1 Antibodies)/STAT3 (show STAT3 Antibodies) signaling.
Data indicate that simultaneous determination of serum galectin-3 (show LGALS3 Antibodies) and -4 levels in a single assay provides a high specificity and sensitivity in distinguishing colorectal cancer patients without metastases from those with liver metastases.
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. The expression of this gene is restricted to small intestine, colon, and rectum, and it is underexpressed in colorectal cancer.
lectin, galactoside-binding, soluble, 4
, lectin, galactoside-binding, soluble, 4 (galectin 4)
, galectin family xgalectin-VIa
, lactose-binding lectin 4
, L-36 lactose binding protein
, L-36 lactose-binding protein
, Lectin galactose binding soluble 4 (Galectin-4)
, Lectin, galactose binding, soluble 4 (Galectin-4)
, antigen NY-CO-27
, galectin 4